Ikarian Capital, LLC - Dec 31, 2024 SCHEDULE 13G Report for Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Forte Biosciences, Inc. Common Stock, $0.001 par value
Symbol: FBRX
Shares outstanding: 6.41M shares
Disclosed Ownership: 609K shares
Ownership: 9.5%
Form type: SCHEDULE 13G
Date filed: 2/14/2025, 01:15 PM
Date of event: Dec 31, 2024
Next filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	9.5%	609K	0	609K	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	9.5%	609K	0	609K	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager